ProMIS Neurosciences, Inc.

US$4.16As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PMNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (30.03%)
Div yield —
ROE (172.30%)
Biotechnology
Beta (5Y) (0.21)
PE TTM —
TSR TTM (59.91%)
Mkt cap US$37.31M
ROIC (109.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.61
10.73%
27.42%
Hold 1|3|7|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.09
0.10
0.11
7.54%
13.32%
16.50%
20.55%
Revenue$M
3.139
3.163
3.145
3.145
3.24%
0.80%
2.76%
0.06%
Peers (US$37.31M)
Cap (US$)
PE
37.25M
—
Capital
TTM
5Y
10Y
Leveragex
0.194
0.625
0.506
EBIT/Intx
16.95
0.147
0.158
Own earn%
76.99
42.90
52.32
Sh yield%
16.89
15.39
16.76
Owners
Insiders/Inst%
2.51
47.21
Short interest%
3.63
SBC / revenue%
1.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
23–27
$1 testx
—
Incr. ROIC%
1